|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2
|
Sauer R, Becker H, Hohenberger W, Rodel C,
Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF,
Karstens JH, Liersch T, Schmidberger H and Raab R; German Rectal
Cancer Study Group. Preoperative versus postoperative
chemoradiotherapy for rectal cancer. N Engl J Med. 351:1731–1740.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Roh MS, Colangelo LH, O’Connell MJ,
Yothers G, Deutsch M, Allegra CJ, Kahlenberg MS, Baez-Diaz L,
Ursiny CS, Petrelli NJ and Wolmark N: Preoperative multimodality
therapy improves disease-free survival in patients with carcinoma
of the rectum: NSABP R-03. J Clin Oncol. 27:5124–5130. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Maas M, Nelemans PJ, Valentini V, Das P,
Rödel C, Kuo LJ, Calvo FA, García-Aguilar J, Glynne-Jones R,
Haustermans K, Mohiuddin M, Pucciarelli S, Small W Jr, Suárez J,
Theodoropoulos G, Biondo S, Beets-Tan RG and Beets GL: Long-term
outcome in patients with a pathological complete response after
chemoradiation for rectal cancer: a pooled analysis of individual
patient data. Lancet Oncol. 11:835–844. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sprenger T, Rödel F, Beissbarth T, Conradi
LC, Rothe H, Homayounfar K, Wolff HA, Ghadimi BM, Yildirim M,
Becker H, Rödel C and Liersch T: Failure of downregulation of
survivin following neoadjuvant radiochemotherapy in rectal cancer
is associated with distant metastases and shortened survival. Clin
Cancer Res. 17:1623–1631. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Edden Y, Wexner SD and Berho M: The use of
molecular markers as a method to predict the response to
neoadjuvant therapy for advanced stage rectal adenocarcinoma.
Colorectal Dis. 14:555–561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Trakarnsanga A, Ithimakin S and Weiser MR:
Treatment of locally advanced rectal cancer: controversies and
questions. World J Gastroenterol. 18:5521–5532. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chin KF, Greenman J, Gardiner E, Kumar H,
Topping K and Monson J: Pre-operative serum vascular endothelial
growth factor can select patients for adjuvant treatment after
curative resection in colorectal cancer. Br J Cancer. 83:1425–1431.
2000. View Article : Google Scholar
|
|
9
|
Cascinu S, Graziano F, Catalano V,
Staccioli MP, Rossi MC, Baldelli AM, Barni S, Brenna A, Secondino
S, Muretto P and Catalano G: An analysis of p53, BAX and vascular
endothelial growth factor expression in node-positive rectal
cancer. Relationships with tumour recurrence and event-free
survival of patients treated with adjuvant chemoradiation. Br J
Cancer. 86:744–749. 2002. View Article : Google Scholar
|
|
10
|
Willett CG, Duda DG, di Tomaso E, Boucher
Y, Ancukiewicz M, Sahani DV, Lahdenranta J, Chung DC, Fischman AJ,
Lauwers GY, Shellito P, Czito BG, Wong TZ, Paulson E, Poleski M,
Vujaskovic Z, Bentley R, Chen HX, Clark JW and Jain RK: Efficacy,
safety, and biomarkers of neoadjuvant bevacizumab, radiation
therapy, and fluorouracil in rectal cancer: a multidisciplinary
phase II study. J Clin Oncol. 27:3020–3026. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brizel DM, Scully SP, Harrelson JM,
Layfield LJ, Bean JM, Prosnitz LR and Dewhirst MW: Tumor
oxygenation predicts for the likelihood of distant metastases in
human soft tissue sarcoma. Cancer Res. 56:941–943. 1996.PubMed/NCBI
|
|
12
|
Nordsmark M, Alsner J, Keller J, Nielsen
OS, Jensen OM, Horsman MR and Overgaard J: Hypoxia in human soft
tissue sarcomas: adverse impact on survival and no association with
p53 mutations. Br J Cancer. 84:1070–1075. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koukourakis MI, Bentzen SM, Giatromanolaki
A, Wilson GD, Daley FM, Saunders MI, Dische S, Sivridis E and
Harris AL: Endogenous markers of two separate hypoxia response
pathways (hypoxia inducible factor 2 alpha and carbonic anhydrase
9) are associated with radiotherapy failure in head and neck cancer
patients recruited in the CHART randomized trial. J Clin Oncol.
24:727–735. 2006. View Article : Google Scholar
|
|
14
|
Sowter HM, Ratcliffe PJ, Watson P,
Greenberg AH and Harris AL: HIF-1-dependent regulation of hypoxic
induction of the cell death factors BNIP3 and NIX in human tumors.
Cancer Res. 61:6669–6673. 2001.PubMed/NCBI
|
|
15
|
Lal A, Peters H, St Croix B, Haroon ZA,
Dewhirst MW, Strausberg RL, Kaanders JH, van der Kogel AJ and
Riggins GJ: Transcriptional response to hypoxia in human tumors. J
Natl Cancer Inst. 93:1337–1343. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhong H, De Marzo AM, Laughner E, Lim M,
Hilton DA, Zagzag D, Buechler P, Isaacs WB, Semenza GL and Simons
JW: Overexpression of hypoxia-inducible factor 1 alpha in common
human cancers and their metastases. Cancer Res. 59:5830–5835.
1999.PubMed/NCBI
|
|
17
|
Ishigami SI, Arii S, Furutani M, Niwano M,
Harada T, Mizumoto M, Mori A, Onodera H and Imamura M: Predictive
value of vascular endothelial growth factor (VEGF) in metastasis
and prognosis of human colorectal cancer. Br J Cancer.
78:1379–1384. 1998. View Article : Google Scholar
|
|
18
|
Rajaganeshan R, Prasad R, Guillou PJ,
Poston G, Scott N and Jayne DG: The role of hypoxia in recurrence
following resection of Dukes’ B colorectal cancer. Int J Colorectal
Dis. 23:1049–1055. 2008.PubMed/NCBI
|
|
19
|
Wei SC, Liang JT, Tsao PN, Hsieh FJ, Yu SC
and Wong JM: Preoperative serum placenta growth factor level is a
prognostic biomarker in colorectal cancer. Dis Colon Rectum.
52:1630–1636. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Saigusa S, Toiyama Y, Tanaka K, Yokoe T,
Okugawa Y, Fujikawa H, Matsusita K, Kawamura M, Inoue Y, Miki C and
Kusunoki M: Cancer-associated fibroblasts correlate with poor
prognosis in rectal cancer after chemoradiotherapy. Int J Oncol.
38:655–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM and Haller DG: AJCC Cancer Staging Handbook - TNM
Classification of Malignant Tumors. 6th edition. Springer-Verlag;
New York: 2002
|
|
22
|
Dworak O, Keilholz L and Hoffmann A:
Pathological features of rectal cancer after preoperative
radiochemotherapy. Int J Colorectal Dis. 12:19–23. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Müller A, Homey B, Soto H, Ge N, Catron D,
Buchanan ME, McClanahan T, Murphy E, Yuan W, Wagner SN, Barrera JL,
Mohar A, Verastegui E and Zlotnik A: Involvement of chemokine
receptors in breast cancer metastasis. Nature. 410:50–56.
2001.PubMed/NCBI
|
|
24
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar
|
|
25
|
Schrader AJ, Lechner O, Templin M, Dittmar
KE, Machtens S, Mengel M, Probst-Kepper M, Franzke A, Wollensak T,
Gatzlaff P, Atzpodien J, Buer J and Lauber J: CXCR4/CXCL12
expression and signalling in kidney cancer. Br J Cancer.
86:1250–1256. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Taichman RS, Cooper C, Keller ET, Pienta
KJ, Taichman NS and McCauley LK: Use of the stromal cell-derived
factor-1/CXCR4 pathway in prostate cancer metastasis to bone.
Cancer Res. 62:1832–1837. 2002.PubMed/NCBI
|
|
27
|
Matsusue R, Kubo H, Hisamori S, Okoshi K,
Takagi H, Hida K, Nakano K, Itami A, Kawada K, Nagayama S and Sakai
Y: Hepatic stellate cells promote liver metastasis of colon cancer
cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol.
16:2645–2653. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoshitake N, Fukui H, Yamagishi H,
Sekikawa A, Fujii S, Tomita S, Ichikawa K, Imura J, Hiraishi H and
Fujimori T: Expression of SDF-1 alpha and nuclear CXCR4 predicts
lymph node metastasis in colorectal cancer. Br J Cancer.
98:1682–1689. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Heckmann D, Laufs S, Maier P, Zucknick M,
Giordano FA, Veldwijk MR, Eckstein V, Wenz F, Zeller WJ, Fruehauf S
and Allgayer H: A Lentiviral CXCR4 overexpression and knockdown
model in colorectal cancer cell lines reveals plerixafor-dependent
suppression of SDF-1α-induced migration and invasion. Onkologie.
34:502–508. 2011.PubMed/NCBI
|
|
30
|
Wei SC, Tsao PN, Yu SC, Shun CT, Tsai-Wu
JJ, Wu CH, Su YN, Hsieh FJ and Wong JM: Placenta growth factor
expression is correlated with survival of patients with colorectal
cancer. Gut. 54:666–672. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Carmeliet P, Moons L, Luttun A, Vincenti
V, Compernolle V, De Mol M, Wu Y, Bono F, Devy L, Beck H, Scholz D,
Acker T, DiPalma T, Dewerchin M, Noel A, Stalmans I, Barra A,
Blacher S, VandenDriessche T, Ponten A, Eriksson U, Plate KH,
Foidart JM, Schaper W, Charnock-Jones DS, Hicklin DJ, Herbert JM,
Collen D and Persico MG: Synergism between vascular endothelial
growth factor and placental growth factor contributes to
angiogenesis and plasma extravasation in pathological conditions.
Nat Med. 7:575–583. 2001. View
Article : Google Scholar
|
|
32
|
Fischer C, Jonckx B, Mazzone M, Zacchigna
S, Loges S, Pattarini L, Chorianopoulos E, Liesenborghs L, Koch M,
De Mol M, Autiero M, Wyns S, Plaisance S, Moons L, van Rooijen N,
Giacca M, Stassen JM, Dewerchin M, Collen D and Carmeliet P:
Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors
without affecting healthy vessels. Cell. 131:463–475. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Landriscina M, Cassano A, Ratto C, Longo
R, Ippoliti M, Palazzotti B, Crucitti F and Barone C: Quantitative
analysis of basic fibroblast growth factor and vascular endothelial
growth factor in human colorectal cancer. Br J Cancer. 78:765–770.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Adini A, Kornaga T, Firoozbakht F and
Benjamin LE: Placental growth factor is a survival factor for tumor
endothelial cells and macrophages. Cancer Res. 62:2749–2752.
2002.PubMed/NCBI
|
|
35
|
Lee JC, Chow NH, Wang ST and Huang SM:
Prognostic value of vascular endothelial growth factor expression
in colorectal cancer patients. Eur J Cancer. 36:748–753. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Khorana AA, Ryan CK, Cox C, Eberly S and
Sahasrabudhe DM: Vascular endothelial growth factor, CD68, and
epidermal growth factor receptor expression and survival in
patients with stage II and stage III colon carcinoma: a role for
the host response in prognosis. Cancer. 97:960–968. 2003.
View Article : Google Scholar
|
|
37
|
Lee-Kong SA, Ruby JA, Chessin DB,
Pucciarelli S, Shia J, Riedel ER, Nitti D and Guillem JG:
Hypoxia-related proteins in patients with rectal cancer undergoing
neoadjuvant combined modality therapy. Dis Colon Rectum.
55:990–995. 2012. View Article : Google Scholar : PubMed/NCBI
|
